Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Urapidil
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Aging
1 trial -
Urinary kallidinogenase for injection
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
Use baby moisturizers by NeoChine
The First People's Hospital of Lianyungang
Neonatal Jaundice
1 trial -
Using medical biological glue for filling And Using the meniscus suture system
The First People's Hospital of Lianyungang
Unilateral Meniscus Tear of the Knee Joint
1 trial -
Usual care
Eye & ENT Hospital of Fudan University
Vestibular Disorder
1 trial -
Vaginal progesterone
Hospital Authority, Hong Kong
Preterm Birth
1 trial -
Valerian
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Menopausal Women
1 trial -
Venclexta 100 MG Oral Tablet
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Venetoclax : 100mg on day 1, 200mg on day 2, 400mg on days 3 to 8; oral administration;
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Vildagliptin 50 mg bid
The First People's Hospital of Lianyungang
Parkinson's Disease
1 trial -
Village doctor-led tailored health management
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiovascular Diseases
1 trial -
Vitamin A
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Vitamin A Deficiency
1 trial -
Vitamin A
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Retinopathy of Prematurity
1 trial -
Vitamin C
The First People's Hospital of Lianyungang
Ageing
1 trial -
Vitamin D
The First People's Hospital of Lianyungang
Development, Child
1 trial -
Vitamin D3
Hospital Authority, Hong Kong
Overweight and Obesity
1 trial -
Vitamin D3
Hospital Authority, Hong Kong
Major Depression
1 trial -
Voglibose tablets
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Heart Disease
1 trial -
Vonoprazan+amoxicillin+doxycycline+bismuth for 14 days
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial -
Walnuts 30 grams
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiovascular Diseases
1 trial -
Xiangsha Liujunzi granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Functional Dyspepsia
1 trial -
Xuebi formula
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetic Peripheral Neuropathy
1 trial -
Yin and Yang tonic granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Osteopenia
1 trial -
Yinxingmihuan oral solution
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Stable Angina
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources